Christopher Moore

3.4k total citations · 1 hit paper
53 papers, 2.0k citations indexed

About

Christopher Moore is a scholar working on Molecular Biology, Physiology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Christopher Moore has authored 53 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 11 papers in Physiology and 10 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Christopher Moore's work include Cancer Immunotherapy and Biomarkers (5 papers), PI3K/AKT/mTOR signaling in cancer (4 papers) and Platelet Disorders and Treatments (4 papers). Christopher Moore is often cited by papers focused on Cancer Immunotherapy and Biomarkers (5 papers), PI3K/AKT/mTOR signaling in cancer (4 papers) and Platelet Disorders and Treatments (4 papers). Christopher Moore collaborates with scholars based in United Kingdom, United States and Germany. Christopher Moore's co-authors include Julian Downward, Sareena Rana, Míriam Molina‐Arcas, Bradley Spencer‐Dene, Emma Nye, Philip East, Davide Zecchin, Sophie de Carné Trécesson, Perry J. Blackshear and Wi S. Lai and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Immunity.

In The Last Decade

Christopher Moore

49 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Oncogenic RAS Signaling Promotes Tumor Immunoresistance by Stabilizing PD-L1 mRNA

2017 474 citations Sophie de Carné Trécesson, Sareena Rana et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Christopher Moore United Kingdom	25	906	589	465	261	165	53	2.0k
Pedro Gascón United States	32	1.1k 1.2×	694 1.2×	529 1.1×	308 1.2×	251 1.5×	60	3.2k
Mónika Göőz United States	24	754 0.8×	282 0.5×	313 0.7×	185 0.7×	145 0.9×	60	1.8k
Guoliang Wang China	23	748 0.8×	353 0.6×	180 0.4×	432 1.7×	120 0.7×	149	2.0k
Seiji Nomura Japan	27	624 0.7×	556 0.9×	294 0.6×	246 0.9×	64 0.4×	98	2.2k
Laurent Martin France	32	699 0.8×	515 0.9×	473 1.0×	568 2.2×	218 1.3×	156	2.9k
Yuki Tanaka Japan	22	1.0k 1.2×	336 0.6×	434 0.9×	169 0.6×	169 1.0×	120	2.6k
Lisa F. Lincz Australia	29	930 1.0×	324 0.6×	252 0.5×	154 0.6×	168 1.0×	81	2.3k
Michele Sanicola United States	24	2.0k 2.2×	492 0.8×	345 0.7×	208 0.8×	144 0.9×	32	3.5k
Hua Li China	30	1.0k 1.1×	421 0.7×	249 0.5×	374 1.4×	221 1.3×	103	2.8k
Shigeto Matsushita Japan	29	878 1.0×	883 1.5×	291 0.6×	344 1.3×	154 0.9×	125	2.7k

Countries citing papers authored by Christopher Moore

Since Specialization

Citations

This map shows the geographic impact of Christopher Moore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Moore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Moore more than expected).

Fields of papers citing papers by Christopher Moore

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher Moore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Moore. The network helps show where Christopher Moore may publish in the future.

Co-authorship network of co-authors of Christopher Moore

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher Moore. A scholar is included among the top collaborators of Christopher Moore based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher Moore. Christopher Moore is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Boumelha, Jesse, Nourdine Bah, Hongui Cha, et al.. (2024). CRISPR–Cas9 Screening Identifies KRAS-Induced COX2 as a Driver of Immunotherapy Resistance in Lung Cancer. Cancer Research. 84(14). 2231–2246. 10 indexed citations

Anastasiou, Panayiotis, Christopher Moore, Sareena Rana, et al.. (2024). Combining RAS(ON) G12C-selective inhibitor with SHP2 inhibition sensitises lung tumours to immune checkpoint blockade. Nature Communications. 15(1). 8146–8146. 5 indexed citations

Mitchell, Sally A., et al.. (2024). Stunned Myocardium as a Sequela of Acute Severe Anemia: An Adult Simulation Case for Anesthesiology Residents. MedEdPORTAL. 20. 11432–11432.

Mugarza, Edurne, Febe van Maldegem, Jesse Boumelha, et al.. (2022). Therapeutic KRAS ^G12C inhibition drives effective interferon-mediated antitumor immunity in immunogenic lung cancers. Science Advances. 8(29). eabm8780–eabm8780. 73 indexed citations

Thin, May Zaw, Christopher Moore, Thomas J. Snoeks, et al.. (2022). Micro-CT acquisition and image processing to track and characterize pulmonary nodules in mice. Nature Protocols. 18(3). 990–1015. 12 indexed citations

Maldegem, Febe van, Harshil Patel, Mihaela Angelova, et al.. (2021). Characterisation of tumour microenvironment remodelling following oncogene inhibition in preclinical studies with imaging mass cytometry. Nature Communications. 12(1). 5906–5906. 41 indexed citations

Zecchin, Davide, Christopher Moore, Stuart Horswell, et al.. (2020). Combined targeting of G protein‐coupled receptor and EGF receptor signaling overcomes resistance to PI 3K pathway inhibitors in PTEN ‐null triple negative breast cancer. EMBO Molecular Medicine. 12(8). e11987–e11987. 19 indexed citations

Molina‐Arcas, Míriam, Christopher Moore, Sareena Rana, et al.. (2019). Development of combination therapies to maximize the impact of KRAS-G12C inhibitors in lung cancer. Science Translational Medicine. 11(510). 146 indexed citations

Hancock, David C., Sareena Rana, Philip East, et al.. (2019). RAC1P29S Induces a Mesenchymal Phenotypic Switch via Serum Response Factor to Promote Melanoma Development and Therapy Resistance. Cancer Cell. 36(1). 68–83.e9. 90 indexed citations

10.

Ilnytska, Olga, Marianita Santiana, Nai-Yun Hsu, et al.. (2013). Enteroviruses Harness the Cellular Endocytic Machinery to Remodel the Host Cell Cholesterol Landscape for Effective Viral Replication. Cell Host & Microbe. 14(3). 281–293. 119 indexed citations

11.

Moore, Christopher, David Sanz‐Rosa, & Michael Emerson. (2010). Distinct role and location of the endothelial isoform of nitric oxide synthase in regulating platelet aggregation in males and females in vivo. European Journal of Pharmacology. 651(1-3). 152–158. 24 indexed citations

12.

Douglas, Catriona M., Christopher Moore, Andrew Sykes, et al.. (2010). Electroglottogram approximate entropy: a novel single parameter for objective voice assessment. The Journal of Laryngology & Otology. 124(5). 520–528. 7 indexed citations

13.

Jones, Sarah, David Sanz‐Rosa, Christopher Moore, et al.. (2010). The plasma membrane calcium ATPase modulates calcium homeostasis, intracellular signaling events and function in platelets. Journal of Thrombosis and Haemostasis. 8(12). 2766–2774. 21 indexed citations

14.

Moore, Christopher, et al.. (2009). Platelet aggregation responses are critically regulated in vivo by endogenous nitric oxide but not by endothelial nitric oxide synthase. British Journal of Pharmacology. 158(7). 1735–1742. 42 indexed citations

15.

Moore, Christopher, et al.. (2005). Voice Abnormality in Adults with Congenital and Adult-Acquired Growth Hormone Deficiency. The Journal of Clinical Endocrinology & Metabolism. 90(7). 4128–4132. 10 indexed citations

16.

O’Boyle, Donald J., et al.. (2001). Human locognosic acuity on the arm varies with explicit and implicit manipulations of attention: implications for interpreting elevated tactile acuity on an amputation stump. Neuroscience Letters. 305(1). 37–40. 12 indexed citations

17.

Moore, Christopher. (2000). Investigation of the functional correlates of reorganization within the human somatosensory cortex. Brain. 123(9). 1883–1895. 38 indexed citations

18.

Moore, Christopher, et al.. (1999). Cortical focusing is an alternative explanation for improved sensory acuity on an amputation stump. Neuroscience Letters. 270(3). 185–187. 12 indexed citations

19.

McMahon, Stephen B. & Christopher Moore. (1988). Plasticity of primary afferent acid phosphatase expression following rerouting of afferents from muscle to skin in the adult rat. The Journal of Comparative Neurology. 274(1). 1–8. 31 indexed citations

20.

Schwartz, Robert A., et al.. (1984). Linear Localized Coumarin Necrosis. Dermatology. 168(1). 31–34. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact